Evidence map›Paper›PMID 22962029›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2012

Inverting the regioselectivity of the berberine bridge enzyme by employing customized fluorine-containing substrates.

Verena Resch, Horst Lechner, Joerg H Schrittwieser, Silvia Wallner, Karl Gruber, Peter Macheroux, Wolfgang Kroutil

Open access · bronzeAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Structure and Biocatalytic Scope of Coclaurine N-Methyltransferase.Angewandte Chemie (International ed. in English) · 2018
    Article
  5. Article
  6. Article
  7. Deracemization by simultaneous bio-oxidative kinetic resolution and stereoinversion.Angewandte Chemie (International ed. in English) · 2014
    Article
  8. Review
  9. Article
  10. Asymmetric Preparation ofOrganic process research & development · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Verena ReschDepartment of Chemistry, Organic and Bioorganic Chemistry, University of Graz, Heinrichstrasse 28, 8010 Graz, Austria.
Horst Lechner
Joerg H Schrittwieser
Silvia Wallner
Karl Gruber
Peter Macheroux
Wolfgang Kroutil
University of Graz · ATGraz University of Technology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorine is commonly applied in pharmaceuticals to block the degradation of bioactive compounds at a specific site of the molecule. Blocking of the reaction center of the enzyme-catalyzed ring closure of 1,2,3,4-tetrahydrobenzylisoquinolines by a fluoro moiety allowed redirecting the berberine bridge enzyme (BBE)-catalyzed transformation of these compounds to give the formation of an alternative regioisomeric product namely 11-hydroxy-functionalized tetrahydroprotoberberines instead of the commonly formed 9-hydroxy-functionalized products. Alternative strategies to change the regioselectivity of the enzyme, such as protein engineering, were not applicable in this special case due to missing substrate-enzyme interactions. Medium engineering, as another possible strategy, had clear influence on the regioselectivity of the reaction pathway, but did not lead to perfect selectivity. Thus, only substrate tuning by introducing a fluoro moiety at one potential reactive carbon center switched the reaction to the formation of exclusively one regioisomer with perfect enantioselectivity.

Indexed as

FluorineIsoquinolinesMagnetic Resonance SpectroscopyMolecular StructureOxidoreductases, N-DemethylatingStereoisomerismSubstrate SpecificityFluorineIsoquinolinesOxidoreductases, N-Demethylatingreticuline oxidase

Identifiers

PMID22962029
PMCPMC3533790
OpenAlexW2158408640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.